Alibaba Health Information Technology Limited
ALBBY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.16 | 0.78 | -0.42 | 1.22 |
| FCF Yield | 1.98% | 2.64% | 0.37% | 0.72% |
| EV / EBITDA | 41.59 | 36.72 | -2,305.59 | -245.96 |
| Quality | ||||
| ROIC | 8.80% | 4.09% | -0.20% | -8.04% |
| Gross Margin | 24.29% | 21.81% | 21.30% | 19.96% |
| Cash Conversion Ratio | 0.89 | 1.15 | 0.48 | -1.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.57% | 9.51% | 19.92% | 28.95% |
| Free Cash Flow Growth | 30.19% | 322.69% | -38.92% | -58.74% |
| Safety | ||||
| Net Debt / EBITDA | -1.35 | -3.41 | 442.84 | 55.35 |
| Interest Coverage | 604.09 | 107.25 | -5.45 | -287.93 |
| Efficiency | ||||
| Inventory Turnover | 16.37 | 15.10 | 10.02 | 10.62 |
| Cash Conversion Cycle | 2.09 | -23.09 | -20.04 | -34.69 |